Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements - Summary of Impact of Revision on Stockholders' Equity (Deficit) (Details)

v3.21.4
Restatement of Previously Issued Financial Statements - Summary of Impact of Revision on Stockholders' Equity (Deficit) (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]      
Sale of 27,600,000 Units, net of underwriting discount and offering expenses   2,760 2,760
Change in common stock subject to possible redemption $ 0    
Common stock subject to possible redemption   $ (2,760) $ (2,760)
Sale of 7,270,000 Private Placement Warrants through over-allotment   7,270,000 7,270,000
Subsequent remeasurement under ASC 480-10-S99   $ (15,816,086) $ (15,816,086)
As Previously Reported      
Error Corrections and Prior Period Adjustments Restatement [Line Items]      
Sale of 27,600,000 Units, net of underwriting discount and offering expenses   267,453,914 267,453,914
Change in common stock subject to possible redemption 119,590 $ (262,428,430) $ (262,308,840)
Adjustment      
Error Corrections and Prior Period Adjustments Restatement [Line Items]      
Sale of 27,600,000 Units, net of underwriting discount and offering expenses   (267,451,154) (267,451,154)
Change in common stock subject to possible redemption $ (119,590) $ 262,428,430 $ 262,308,840
Common stock subject to possible redemption   (2,760) (2,760)
Sale of 7,270,000 Private Placement Warrants through over-allotment   7,270,000 7,270,000
Subsequent remeasurement under ASC 480-10-S99   $ (15,816,086) $ (15,816,086)